Ticagrelor induces adenosine triphosphate release from human red blood cells

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 754-758

  Öhman, Jenny ^a   Kudira, Ramesh ^a   Albinsson, Sebastian ^b   Olde, Björn ^a   Erlinge, David ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adenosine; ATP; Erythrocyte; Purinergic; Ticagrelor

Indexed keywords

ADENOSINE TRIPHOSPHATE; TICAGRELOR;

ARTICLE; BIOLUMINESCENCE; DEPOLARIZATION; DOSE RESPONSE; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE CHANNEL; PRIORITY JOURNAL;

ADENOSINE; ADENOSINE TRIPHOSPHATE; CELLS, CULTURED; ERYTHROCYTES; HUMANS; INHIBITORY CONCENTRATION 50; PURINERGIC P2Y RECEPTOR ANTAGONISTS;

EID: 84857444798     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.093     Document Type: Article

References (16)

1. Nawarskas J.J., Clark S.M. Ticagrelor: a novel reversible oral antiplatelet agent. Cardiol. Rev. 2011, 19:95-100.
2. Wallentin L., Becker R.C., Budaj A., Cannon C.P., Emanuelsson H., Held C., Horrow J., Husted S., James S., Katus H., Mahaffey K.W., Scirica B.M., Skene A., Steg P.G., Storey R.F., Harrington R.A., Freij A., Thorsen M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2009, 361:1045-1057.
3. Gurbel P.A., Bliden K.P., Butler K., Tantry U.S., Gesheff T., Wei C., Teng R., Antonino M.J., Patil S.B., Karunakaran A., Kereiakes D.J., Parris C., Purdy D., Wilson V., Ledley G.S., Storey R.F. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009, 120:2577-2585.
4. Scirica B.M., Cannon C.P., Emanuelsson H., Michelson E.L., Harrington R.A., Husted S., James S., Katus H., Pais P., Raev D., Spinar J., Steg P.G., Storey R.F., Wallentin L. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J. Am. Coll. Cardiol. 2011, 57:1908-1916.
5. Storey R.F., Becker R.C., Harrington R.A., Husted S., James S.K., Cools F., Steg P.G., Khurmi N.S., Emanuelsson H., Cooper A., Cairns R., Cannon C.P., Wallentin L. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur. Heart J. 2011.
6. Ellsworth M.L., Ellis C.G., Goldman D., Stephenson A.H., Dietrich H.H., Sprague R.S. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 2009, 24:107-116.
7. van Giezen J.J., Sidaway J., Glaves P., Kirk I., Bjorkman J.A. Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. J. Cardiovasc. Pharmacol. Ther. 2011.
8. Dietrich H.H., Ellsworth M.L., Sprague R.S., Dacey R.G. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am. J. Physiol. Heart. Circ. Physiol. 2000, 278:H1294-H1298.
9. Gonzalez-Alonso J., Olsen D.B., Saltin B. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ. Res. 2002, 91:1046-1055.
10. Sprague R.S., Ellsworth M.L., Stephenson A.H., Lonigro A.J. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am. J. Physiol. Cell Physiol. 2001, 281:C1158-C1164.
11. Bencic D.C., Yates T.J., Ingermann R.L. Ecto-ATPase activity of vertebrate blood cells. Physiol. Zool. 1997, 70:621-630.
12. Burki N.K., Dale W.J., Lee L.Y. Intravenous adenosine and dyspnea in humans. J. Appl. Physiol. 2005, 98:180-185.
13. Storey R.F., Becker R.C., Harrington R.A., Husted S., James S.K., Cools F., Steg P.G., Khurmi N.S., Emanuelsson H., Lim S.T., Cannon C.P., Katus H.A., Wallentin L. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Am. J. Cardiol. 2011.
14. L.-M. Gan, A. Wittfeldt, H. Emanuelsson, S. Nylander, M. Andersson, Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans? A randomised double-blind placebo-controlled crossover single centre study using transthoracic color doppler echocardiography, TCT 2011, San Fransisco, CA, USA, 2011.
15. Sridharan M., Adderley S.P., Bowles E.A., Egan T.M., Stephenson A.H., Ellsworth M.L., Sprague R.S. Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am. J. Physiol. Heart. Circ. Physiol. 2010, 299:H1146-H1152.
16. Sprague R.S., Ellsworth M.L., Stephenson A.H., Kleinhenz M.E., Lonigro A.J. Deformation-induced ATP release from red blood cells requires CFTR activity. Am. J. Physiol. 1998, 275:H1726-H1732.